The Biden administration wants Medicare and Medicaid to cover GLP-1s. Will the Trump White House allow it?

The Biden ad­min­is­tra­tion pro­posed a new rule Tues­day that would ex­pand Medicare and Med­ic­aid cov­er­age of pop­u­lar obe­si­ty drugs, earn­ing praise from the phar­ma­ceu­ti­cal in­dus­try …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.